readthroughSign in
CompanyASNDNasdaqHellerup

Ascendis Pharma A/S

Ascendis Pharma develops therapeutics using TransCon technology, a prodrug approach that extends drug half-life.

SCHEDULE 13G/ANov 16Latest SEC filing
Nov 12Latest story